Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 827 entries
Sorted by: Best Match Show Resources per page
Increased Vasoocclusive Crises in "O" Blood Group Sickle Cell Disease Patients: Association with Underlying Thrombospondin Levels.

Mediterranean journal of hematology and infectious diseases

Al Huneini M, Alkindi S, Panjwani V, Al Falahi K, Al Balushi B, Gravell D, Ho CH, Krishnamoorthy R, Pathare AV.
PMID: 28512557
Mediterr J Hematol Infect Dis. 2017 Apr 20;9(1):e2017028. doi: 10.4084/MJHID.2017.028. eCollection 2017.

OBJECTIVES: To explore the incidence of vaso-occlusive crisis (VOC) in Blood Group "O" sickle cell disease (SCD) patients, and correlate it with the blood group and thrombospondin (TSP) levels.METHODS: In 89 consecutive SCD patients, blood samples were obtained for...

Cite
Al Huneini M, Alkindi S, Panjwani V, et al. Increased Vasoocclusive Crises in "O" Blood Group Sickle Cell Disease Patients: Association with Underlying Thrombospondin Levels. Mediterr J Hematol Infect Dis. 2017;9(1):e2017028doi: 10.4084/MJHID.2017.028.
Al Huneini, M., Alkindi, S., Panjwani, V., Al Falahi, K., Al Balushi, B., Gravell, D., Ho, C. H., Krishnamoorthy, R., & Pathare, A. V. (2017). Increased Vasoocclusive Crises in "O" Blood Group Sickle Cell Disease Patients: Association with Underlying Thrombospondin Levels. Mediterranean journal of hematology and infectious diseases, 9(1), e2017028. https://doi.org/10.4084/MJHID.2017.028
Al Huneini, M, et al. "Increased Vasoocclusive Crises in "O" Blood Group Sickle Cell Disease Patients: Association with Underlying Thrombospondin Levels." Mediterranean journal of hematology and infectious diseases vol. 9,1 (2017): e2017028. doi: https://doi.org/10.4084/MJHID.2017.028
Al Huneini M, Alkindi S, Panjwani V, Al Falahi K, Al Balushi B, Gravell D, Ho CH, Krishnamoorthy R, Pathare AV. Increased Vasoocclusive Crises in "O" Blood Group Sickle Cell Disease Patients: Association with Underlying Thrombospondin Levels. Mediterr J Hematol Infect Dis. 2017 Apr 20;9(1):e2017028. doi: 10.4084/MJHID.2017.028. eCollection 2017. PMID: 28512557; PMCID: PMC5419181.
Copy Download .nbib Format: NLM
Spirometric Evaluation of Pulmonary Function in Nigerian Children underwent Bone Marrow Transplantation for Sickle Cell Anemia.

Mediterranean journal of hematology and infectious diseases

Isgro' A, Marziali M, Paciaroni K, De Angelis G, Alfieri C, Ribersani M, Olowoselu FO, Lucarelli G, Gaziev J.
PMID: 28512559
Mediterr J Hematol Infect Dis. 2017 Apr 15;9(1):e2017030. doi: 10.4084/MJHID.2017.030. eCollection 2017.

No abstract available.

Cite
Isgro' A, Marziali M, Paciaroni K, et al. Spirometric Evaluation of Pulmonary Function in Nigerian Children underwent Bone Marrow Transplantation for Sickle Cell Anemia. Mediterr J Hematol Infect Dis. 2017;9(1):e2017030doi: 10.4084/MJHID.2017.030.
Isgro', A., Marziali, M., Paciaroni, K., De Angelis, G., Alfieri, C., Ribersani, M., Olowoselu, F. O., Lucarelli, G., & Gaziev, J. (2017). Spirometric Evaluation of Pulmonary Function in Nigerian Children underwent Bone Marrow Transplantation for Sickle Cell Anemia. Mediterranean journal of hematology and infectious diseases, 9(1), e2017030. https://doi.org/10.4084/MJHID.2017.030
Isgro', Antonella, et al. "Spirometric Evaluation of Pulmonary Function in Nigerian Children underwent Bone Marrow Transplantation for Sickle Cell Anemia." Mediterranean journal of hematology and infectious diseases vol. 9,1 (2017): e2017030. doi: https://doi.org/10.4084/MJHID.2017.030
Isgro' A, Marziali M, Paciaroni K, De Angelis G, Alfieri C, Ribersani M, Olowoselu FO, Lucarelli G, Gaziev J. Spirometric Evaluation of Pulmonary Function in Nigerian Children underwent Bone Marrow Transplantation for Sickle Cell Anemia. Mediterr J Hematol Infect Dis. 2017 Apr 15;9(1):e2017030. doi: 10.4084/MJHID.2017.030. eCollection 2017. PMID: 28512559; PMCID: PMC5419180.
Copy Download .nbib Format: NLM
BCR Signaling Inhibitors: an Overview of Toxicities Associated with Ibrutinib and Idelalisib in Patients with Chronic Lymphocytic Leukemia.

Mediterranean journal of hematology and infectious diseases

Falchi L, Baron JM, Orlikowski CA, Ferrajoli A.
PMID: 26977270
Mediterr J Hematol Infect Dis. 2016 Feb 10;8(1):e2016011. doi: 10.4084/MJHID.2016.011. eCollection 2016.

The B-cell receptor (BCR) signaling inhibitors ibrutinib and idelalisib are revolutionizing the treatment of chronic lymphocytic leukemia (CLL) and other B-cell malignancies. These oral agents, both alone and in combination with other drugs, have shown remarkable clinical activity in...

Cite
Falchi L, Baron JM, Orlikowski CA, et al. BCR Signaling Inhibitors: an Overview of Toxicities Associated with Ibrutinib and Idelalisib in Patients with Chronic Lymphocytic Leukemia. Mediterr J Hematol Infect Dis. 2016;8(1):e2016011doi: 10.4084/MJHID.2016.011.
Falchi, L., Baron, J. M., Orlikowski, C. A., & Ferrajoli, A. (2016). BCR Signaling Inhibitors: an Overview of Toxicities Associated with Ibrutinib and Idelalisib in Patients with Chronic Lymphocytic Leukemia. Mediterranean journal of hematology and infectious diseases, 8(1), e2016011. https://doi.org/10.4084/MJHID.2016.011
Falchi, Lorenzo, et al. "BCR Signaling Inhibitors: an Overview of Toxicities Associated with Ibrutinib and Idelalisib in Patients with Chronic Lymphocytic Leukemia." Mediterranean journal of hematology and infectious diseases vol. 8,1 (2016): e2016011. doi: https://doi.org/10.4084/MJHID.2016.011
Falchi L, Baron JM, Orlikowski CA, Ferrajoli A. BCR Signaling Inhibitors: an Overview of Toxicities Associated with Ibrutinib and Idelalisib in Patients with Chronic Lymphocytic Leukemia. Mediterr J Hematol Infect Dis. 2016 Feb 10;8(1):e2016011. doi: 10.4084/MJHID.2016.011. eCollection 2016. PMID: 26977270; PMCID: PMC4771137.
Copy Download .nbib Format: NLM
Influence of Sickle Cell Gene on the Allelic Diversity at the msp-1 locus of Plasmodium falciparum in Adult Patients with Severe Malaria.

Mediterranean journal of hematology and infectious diseases

Patel DK, Mashon RS, Purohit P, Meher S, Dehury S, Marndi C, Das K, Kullu BK, Patel S, Das P.
PMID: 26401239
Mediterr J Hematol Infect Dis. 2015 Aug 24;7(1):e2015050. doi: 10.4084/MJHID.2015.050. eCollection 2015.

Although several studies have supported that sickle cell trait (HbAS) protects against falciparum malaria, the exact mechanism by which sickle gene confers protection is unclear. Further, there is no information on the influence of the sickle gene on the...

Cite
Patel DK, Mashon RS, Purohit P, et al. Influence of Sickle Cell Gene on the Allelic Diversity at the msp-1 locus of Plasmodium falciparum in Adult Patients with Severe Malaria. Mediterr J Hematol Infect Dis. 2015;7(1):e2015050doi: 10.4084/MJHID.2015.050.
Patel, D. K., Mashon, R. S., Purohit, P., Meher, S., Dehury, S., Marndi, C., Das, K., Kullu, B. K., Patel, S., & Das, P. (2015). Influence of Sickle Cell Gene on the Allelic Diversity at the msp-1 locus of Plasmodium falciparum in Adult Patients with Severe Malaria. Mediterranean journal of hematology and infectious diseases, 7(1), e2015050. https://doi.org/10.4084/MJHID.2015.050
Patel, Dilip Kumar, et al. "Influence of Sickle Cell Gene on the Allelic Diversity at the msp-1 locus of Plasmodium falciparum in Adult Patients with Severe Malaria." Mediterranean journal of hematology and infectious diseases vol. 7,1 (2015): e2015050. doi: https://doi.org/10.4084/MJHID.2015.050
Patel DK, Mashon RS, Purohit P, Meher S, Dehury S, Marndi C, Das K, Kullu BK, Patel S, Das P. Influence of Sickle Cell Gene on the Allelic Diversity at the msp-1 locus of Plasmodium falciparum in Adult Patients with Severe Malaria. Mediterr J Hematol Infect Dis. 2015 Aug 24;7(1):e2015050. doi: 10.4084/MJHID.2015.050. eCollection 2015. PMID: 26401239; PMCID: PMC4560258.
Copy Download .nbib Format: NLM
H1N1 Influenza among Hematological Patients: Monocentric Influenza Cases from 2011 to 2016.

Mediterranean journal of hematology and infectious diseases

Metafuni E, Santangelo R, Chiusolo P, Laurenti L, Sorà F, Giammarco S, Sica S.
PMID: 28293412
Mediterr J Hematol Infect Dis. 2017 Mar 01;9(1):e2017024. doi: 10.4084/MJHID.2017.024. eCollection 2017.

No abstract available.

Cite
Metafuni E, Santangelo R, Chiusolo P, et al. H1N1 Influenza among Hematological Patients: Monocentric Influenza Cases from 2011 to 2016. Mediterr J Hematol Infect Dis. 2017;9(1):e2017024doi: 10.4084/MJHID.2017.024.
Metafuni, E., Santangelo, R., Chiusolo, P., Laurenti, L., Sorà, F., Giammarco, S., & Sica, S. (2017). H1N1 Influenza among Hematological Patients: Monocentric Influenza Cases from 2011 to 2016. Mediterranean journal of hematology and infectious diseases, 9(1), e2017024. https://doi.org/10.4084/MJHID.2017.024
Metafuni, Elisabetta, et al. "H1N1 Influenza among Hematological Patients: Monocentric Influenza Cases from 2011 to 2016." Mediterranean journal of hematology and infectious diseases vol. 9,1 (2017): e2017024. doi: https://doi.org/10.4084/MJHID.2017.024
Metafuni E, Santangelo R, Chiusolo P, Laurenti L, Sorà F, Giammarco S, Sica S. H1N1 Influenza among Hematological Patients: Monocentric Influenza Cases from 2011 to 2016. Mediterr J Hematol Infect Dis. 2017 Mar 01;9(1):e2017024. doi: 10.4084/MJHID.2017.024. eCollection 2017. PMID: 28293412; PMCID: PMC5333735.
Copy Download .nbib Format: NLM
New Insight on Epidemiology and Management of Bacterial Bloodstream Infection in Patients with Hematological Malignancies.

Mediterranean journal of hematology and infectious diseases

Menzo SL, la Martire G, Ceccarelli G, Venditti M.
PMID: 26185609
Mediterr J Hematol Infect Dis. 2015 Jul 01;7(1):e2015044. doi: 10.4084/MJHID.2015.044. eCollection 2015.

Bloodstream infections (BSI) are a significant cause of morbidity and mortality in onco-hematologic patients. The Gram-negative bacteria were the main responsible for the febrile neutropenia in the sixties; their impact declined due to the use of fluoroquinolone prophylaxis. This...

Cite
Menzo SL, la Martire G, Ceccarelli G, et al. New Insight on Epidemiology and Management of Bacterial Bloodstream Infection in Patients with Hematological Malignancies. Mediterr J Hematol Infect Dis. 2015;7(1):e2015044doi: 10.4084/MJHID.2015.044.
Menzo, S. L., la Martire, G., Ceccarelli, G., & Venditti, M. (2015). New Insight on Epidemiology and Management of Bacterial Bloodstream Infection in Patients with Hematological Malignancies. Mediterranean journal of hematology and infectious diseases, 7(1), e2015044. https://doi.org/10.4084/MJHID.2015.044
Menzo, Sara Lo, et al. "New Insight on Epidemiology and Management of Bacterial Bloodstream Infection in Patients with Hematological Malignancies." Mediterranean journal of hematology and infectious diseases vol. 7,1 (2015): e2015044. doi: https://doi.org/10.4084/MJHID.2015.044
Menzo SL, la Martire G, Ceccarelli G, Venditti M. New Insight on Epidemiology and Management of Bacterial Bloodstream Infection in Patients with Hematological Malignancies. Mediterr J Hematol Infect Dis. 2015 Jul 01;7(1):e2015044. doi: 10.4084/MJHID.2015.044. eCollection 2015. PMID: 26185609; PMCID: PMC4500473.
Copy Download .nbib Format: NLM
Drug Therapy in the Progressed CML Patient with multi-TKI Failure.

Mediterranean journal of hematology and infectious diseases

Haznedaroglu IC.
PMID: 25745541
Mediterr J Hematol Infect Dis. 2015 Feb 15;7(1):e2015014. doi: 10.4084/MJHID.2015.014. eCollection 2015.

The aim of this paper is to outline pharmacotherapy of the 'third-line management of CML' (progressive disease course after sequential TKI drugs). Current management of CML with multi-TKI failure is reviewed. TKI (bosutinib, ponatinib, dasatinib, nilotinib) and non-TKI (omacetaxine...

Cite
Haznedaroglu IC. Drug Therapy in the Progressed CML Patient with multi-TKI Failure. Mediterr J Hematol Infect Dis. 2015;7(1):e2015014doi: 10.4084/MJHID.2015.014.
Haznedaroglu, I. C. (2015). Drug Therapy in the Progressed CML Patient with multi-TKI Failure. Mediterranean journal of hematology and infectious diseases, 7(1), e2015014. https://doi.org/10.4084/MJHID.2015.014
Haznedaroglu, Ibrahim C. "Drug Therapy in the Progressed CML Patient with multi-TKI Failure." Mediterranean journal of hematology and infectious diseases vol. 7,1 (2015): e2015014. doi: https://doi.org/10.4084/MJHID.2015.014
Haznedaroglu IC. Drug Therapy in the Progressed CML Patient with multi-TKI Failure. Mediterr J Hematol Infect Dis. 2015 Feb 15;7(1):e2015014. doi: 10.4084/MJHID.2015.014. eCollection 2015. PMID: 25745541; PMCID: PMC4344171.
Copy Download .nbib Format: NLM
Factors influencing adherence to imatinib in Indian chronic myeloid leukemia patients: a cross-sectional study.

Mediterranean journal of hematology and infectious diseases

Kapoor J, Agrawal N, Ahmed R, Sharma SK, Gupta A, Bhurani D.
PMID: 25745540
Mediterr J Hematol Infect Dis. 2015 Feb 20;7(1):e2015013. doi: 10.4084/MJHID.2015.013. eCollection 2015.

Adherence to imatinib(IM) is of utmost importance in patients with chronic myeloid leukemia (CML) to maximise treatment effectiveness. The main objective is to measure adherence to IM by evaluating individual patient characteristics, personal behaviour and, treatment related psychological factors...

Cite
Kapoor J, Agrawal N, Ahmed R, et al. Factors influencing adherence to imatinib in Indian chronic myeloid leukemia patients: a cross-sectional study. Mediterr J Hematol Infect Dis. 2015;7(1):e2015013doi: 10.4084/MJHID.2015.013.
Kapoor, J., Agrawal, N., Ahmed, R., Sharma, S. K., Gupta, A., & Bhurani, D. (2015). Factors influencing adherence to imatinib in Indian chronic myeloid leukemia patients: a cross-sectional study. Mediterranean journal of hematology and infectious diseases, 7(1), e2015013. https://doi.org/10.4084/MJHID.2015.013
Kapoor, Jyotsna, et al. "Factors influencing adherence to imatinib in Indian chronic myeloid leukemia patients: a cross-sectional study." Mediterranean journal of hematology and infectious diseases vol. 7,1 (2015): e2015013. doi: https://doi.org/10.4084/MJHID.2015.013
Kapoor J, Agrawal N, Ahmed R, Sharma SK, Gupta A, Bhurani D. Factors influencing adherence to imatinib in Indian chronic myeloid leukemia patients: a cross-sectional study. Mediterr J Hematol Infect Dis. 2015 Feb 20;7(1):e2015013. doi: 10.4084/MJHID.2015.013. eCollection 2015. PMID: 25745540; PMCID: PMC4344173.
Copy Download .nbib Format: NLM
Osteolytic Bone Lesions - A Rare Presentation of AML M6.

Mediterranean journal of hematology and infectious diseases

Geetha N, Sreelesh KP, Priya MJ, Lali VS, Rekha N.
PMID: 25745544
Mediterr J Hematol Infect Dis. 2015 Feb 15;7(1):e2015017. doi: 10.4084/MJHID.2015.017. eCollection 2015.

Acute myeloid leukemia (AML) M6 is a rare form of AML accounting for < 5 % of all AML. Extramedullary involvement is very rarely seen in this entity. Skeletal lesion has not been described in AML M6 before. We...

Cite
Geetha N, Sreelesh KP, Priya MJ, et al. Osteolytic Bone Lesions - A Rare Presentation of AML M6. Mediterr J Hematol Infect Dis. 2015;7(1):e2015017doi: 10.4084/MJHID.2015.017.
Geetha, N., Sreelesh, K. P., Priya, M. J., Lali, V. S., & Rekha, N. (2015). Osteolytic Bone Lesions - A Rare Presentation of AML M6. Mediterranean journal of hematology and infectious diseases, 7(1), e2015017. https://doi.org/10.4084/MJHID.2015.017
Geetha, N, et al. "Osteolytic Bone Lesions - A Rare Presentation of AML M6." Mediterranean journal of hematology and infectious diseases vol. 7,1 (2015): e2015017. doi: https://doi.org/10.4084/MJHID.2015.017
Geetha N, Sreelesh KP, Priya MJ, Lali VS, Rekha N. Osteolytic Bone Lesions - A Rare Presentation of AML M6. Mediterr J Hematol Infect Dis. 2015 Feb 15;7(1):e2015017. doi: 10.4084/MJHID.2015.017. eCollection 2015. PMID: 25745544; PMCID: PMC4344168.
Copy Download .nbib Format: NLM
Refractory thrombocytopenia and neutropenia: a diagnostic challenge.

Mediterranean journal of hematology and infectious diseases

Gyan E, Dreyfus F, Fenaux P.
PMID: 25745545
Mediterr J Hematol Infect Dis. 2015 Feb 18;7(1):e2015018. doi: 10.4084/MJHID.2015.018. eCollection 2015.

The 2008 WHO classification identified refractory cytopenia with unilineage dysplasia (RCUD) as a composite entity encompassing refractory anemia, refractory thrombocytopenia (RT), and refractory neutropenia (RN), characterized by 10% or more dysplastic cells in the bone marrow respective lineage. The...

Cite
Gyan E, Dreyfus F, Fenaux P. Refractory thrombocytopenia and neutropenia: a diagnostic challenge. Mediterr J Hematol Infect Dis. 2015;7(1):e2015018doi: 10.4084/MJHID.2015.018.
Gyan, E., Dreyfus, F., & Fenaux, P. (2015). Refractory thrombocytopenia and neutropenia: a diagnostic challenge. Mediterranean journal of hematology and infectious diseases, 7(1), e2015018. https://doi.org/10.4084/MJHID.2015.018
Gyan, Emmanuel, et al. "Refractory thrombocytopenia and neutropenia: a diagnostic challenge." Mediterranean journal of hematology and infectious diseases vol. 7,1 (2015): e2015018. doi: https://doi.org/10.4084/MJHID.2015.018
Gyan E, Dreyfus F, Fenaux P. Refractory thrombocytopenia and neutropenia: a diagnostic challenge. Mediterr J Hematol Infect Dis. 2015 Feb 18;7(1):e2015018. doi: 10.4084/MJHID.2015.018. eCollection 2015. PMID: 25745545; PMCID: PMC4344166.
Copy Download .nbib Format: NLM
Study of serum haptoglobin level and its relation to erythropoietic activity in Beta thalassemia children.

Mediterranean journal of hematology and infectious diseases

Ragab SM, Safan MA, Badr EA.
PMID: 25745546
Mediterr J Hematol Infect Dis. 2015 Feb 15;7(1):e2015019. doi: 10.4084/MJHID.2015.019. eCollection 2015.

BACKGROUND: Serum haptoglobin (Hp) is a reliable marker for hemolysis regardless the inflammatory state.OBJECTIVE: We investigated the possible relation between Hp depletion and hemolysis severity, hepatitis C virus (HCV) infection and iron load in β-thalassemia children.METHODS: Twenty two β-thalassemia...

Cite
Ragab SM, Safan MA, Badr EA. Study of serum haptoglobin level and its relation to erythropoietic activity in Beta thalassemia children. Mediterr J Hematol Infect Dis. 2015;7(1):e2015019doi: 10.4084/MJHID.2015.019.
Ragab, S. M., Safan, M. A., & Badr, E. A. (2015). Study of serum haptoglobin level and its relation to erythropoietic activity in Beta thalassemia children. Mediterranean journal of hematology and infectious diseases, 7(1), e2015019. https://doi.org/10.4084/MJHID.2015.019
Ragab, Seham M, et al. "Study of serum haptoglobin level and its relation to erythropoietic activity in Beta thalassemia children." Mediterranean journal of hematology and infectious diseases vol. 7,1 (2015): e2015019. doi: https://doi.org/10.4084/MJHID.2015.019
Ragab SM, Safan MA, Badr EA. Study of serum haptoglobin level and its relation to erythropoietic activity in Beta thalassemia children. Mediterr J Hematol Infect Dis. 2015 Feb 15;7(1):e2015019. doi: 10.4084/MJHID.2015.019. eCollection 2015. PMID: 25745546; PMCID: PMC4344174.
Copy Download .nbib Format: NLM
Successful Management of Pregnancy and Hepatic Toxicity in a CML Female Patient Treated with Nilotinib: a Case Report and a Review.

Mediterranean journal of hematology and infectious diseases

Santorsola D, Abruzzese E.
PMID: 25745547
Mediterr J Hematol Infect Dis. 2015 Feb 15;7(1):e2015020. doi: 10.4084/MJHID.2015.020. eCollection 2015.

We report a case of a young patient with chronic viral hepatitis HBV infection, diagnosed with CML in March 2006 and treated with imatinib 400mg/die as first line therapy with concomitant Lamivudine. Patient obtained a complete hematologic response (CHR)...

Cite
Santorsola D, Abruzzese E. Successful Management of Pregnancy and Hepatic Toxicity in a CML Female Patient Treated with Nilotinib: a Case Report and a Review. Mediterr J Hematol Infect Dis. 2015;7(1):e2015020doi: 10.4084/MJHID.2015.020.
Santorsola, D., & Abruzzese, E. (2015). Successful Management of Pregnancy and Hepatic Toxicity in a CML Female Patient Treated with Nilotinib: a Case Report and a Review. Mediterranean journal of hematology and infectious diseases, 7(1), e2015020. https://doi.org/10.4084/MJHID.2015.020
Santorsola, Domenico, and Abruzzese, Elisabetta. "Successful Management of Pregnancy and Hepatic Toxicity in a CML Female Patient Treated with Nilotinib: a Case Report and a Review." Mediterranean journal of hematology and infectious diseases vol. 7,1 (2015): e2015020. doi: https://doi.org/10.4084/MJHID.2015.020
Santorsola D, Abruzzese E. Successful Management of Pregnancy and Hepatic Toxicity in a CML Female Patient Treated with Nilotinib: a Case Report and a Review. Mediterr J Hematol Infect Dis. 2015 Feb 15;7(1):e2015020. doi: 10.4084/MJHID.2015.020. eCollection 2015. PMID: 25745547; PMCID: PMC4344172.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 827 entries